Balchem Corp. (BCPC) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Balchem’s revenue went from $553M in fiscal 2016 to $1.0B in fiscal 2025, growth of about 7.2% a year.
Net income in fiscal 2025 was $155M, a net margin of 14.9%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $1.1B and net income $171M.
The diluted share count rose 2% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.0B | $954M | $922M | $942M | $799M | $704M | $644M | $644M | $595M | $553M |
| Gross profit | $404M | $371M | $336M | $302M | $280M | $243M | $224M | $211M | $204M | $189M | $181M |
| Operating income | $230M | $209M | $183M | $159M | $145M | $128M | $111M | $103M | $107M | $97M | $91M |
| Net income | $171M | $155M | $128M | $109M | $105M | $96M | $85M | $80M | $79M | $90M | $56M |
| EPS (diluted) | $5.31 | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 |
| R&D | $21M | $19M | $17M | $15M | $12M | $14M | $10M | $11M | $12M | $9M | $7M |
| Revenue growth | — | +8.8% | +3.4% | −2.1% | +17.9% | +13.6% | +9.3% | +0.0% | +8.2% | +7.5% | +0.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $224M | $217M | $182M | $184M | $139M | $161M | $150M | $124M | $119M | $111M | $108M |
| Capital spending | -$46M | — | — | — | -$49M | -$36M | -$32M | -$26M | -$19M | -$28M | -$23M |
| Free cash flow | $178M | — | — | — | $89M | $124M | $118M | $99M | $100M | $83M | $85M |
| Dividends paid | $31M | $28M | $26M | $23M | $21M | $19M | $17M | $15M | $13M | $12M | $11M |
| Buybacks | $126M | $108M | $6M | $4M | $35M | $35M | $13M | $21M | $1M | $2M | $2M |
| Stock-based pay | $20M | $18M | $17M | $16M | $13M | $11M | $8M | $8M | $6M | $6M | $7M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $75M | $50M | $64M | $67M | $103M | $85M | $66M | $54M | $40M | $39M |
| Debt | — | $36M | $35M | $35M | $44M | $21M | $16M | $18M | $156M | $35M | $261M |
| Equity | — | $1.3B | $1.1B | $1.1B | $938M | $877M | $828M | $744M | $692M | $617M | $521M |
| Total assets | — | $1.7B | $1.6B | $1.6B | $1.6B | $1.2B | $1.2B | $1.2B | $981M | $964M | $949M |
| Shares (diluted) | 32M | 33M | 33M | 32M | 32M | 33M | 33M | 33M | 32M | 32M | 32M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 36.5% | 35.7% | 35.2% | 32.8% | 29.8% | 30.4% | 31.8% | 32.8% | 31.7% | 31.8% | 32.7% |
| Operating margin | 20.7% | 20.2% | 19.2% | 17.3% | 15.4% | 16.0% | 15.8% | 15.9% | 16.6% | 16.3% | 16.4% |
| Net margin | 15.4% | 14.9% | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% | 12.4% | 12.2% | 15.1% | 10.1% |
| FCF margin | 16.1% | — | — | — | 9.5% | 15.6% | 16.8% | 15.3% | 15.5% | 14.0% | 15.3% |
| ROIC | — | 12.6% | 11.9% | 11.6% | 11.6% | 10.9% | 10.5% | 11.1% | 10.0% | 11.7% | 7.8% |
| ROE | — | 12.3% | 11.2% | 10.3% | 11.2% | 11.0% | 10.2% | 10.7% | 11.4% | 14.6% | 10.7% |
Frequently asked questions
What is Balchem’s annual revenue?
$1.0B in fiscal 2025 and $1.1B over the twelve months to September 30, 2026.
How much profit does Balchem make?
Net income was $155M in fiscal 2025 (net margin 14.9%).
Is Balchem’s revenue growing?
Yes: revenue rose 8.8% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.